sarah cannon
View Post

A look ahead to 2018 advancements in cancer research with Dr. Spigel

There were many exciting developments in cancer research and care in 2017, including advances in immunotherapy, precision medicine, and prevention. David Spigel, MD, Chief Scientific Officer; Director of Lung Cancer Research Program at Sarah Cannon, HCA’s global cancer institute, recently discussed on Fox & Friends innovations made in the past year, and what is on…
View Post
View Post

Sarah Cannon Expert Comments on Former President Carter’s Cancer Announcement

Dr. Johanna Bendell, Director of the GI Cancer Research Program and Associate Director of the Drug Development Program at Sarah Cannon Research Institute – the research arm of HCA’s global cancer enterprise Sarah Cannon – was featured on CNN, Fox News, and MSNBC Thursday morning to provide insight on former U.S. President Jimmy Carter’s recent…
View Post
View Post

HCA Medical Breakthrough: How Clinical Trials at Sarah Cannon are Leading to New Breakthroughs in Cancer Therapies

Breakthroughs in cancer research have been gaining momentum over the last few years, and particularly in 2014 when the U.S. Food and Drug Administration (FDA) approved 19 new cancer drugs. Sarah Cannon, HCA’s global cancer enterprise, was instrumental in advancing 13 of these new therapies through clinical trials prior to their original FDA approval. Over…
View Post